Advertisement
Research Article

Stage-Specific Inhibition of MHC Class I Presentation by the Epstein-Barr Virus BNLF2a Protein during Virus Lytic Cycle

  • Nathan P. Croft,

    Affiliation: School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom

    X
  • Claire Shannon-Lowe,

    Affiliation: School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom

    X
  • Andrew I. Bell,

    Affiliation: School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom

    X
  • Daniëlle Horst,

    Affiliation: Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands

    X
  • Elisabeth Kremmer,

    Affiliation: Institute of Molecular Immunology, Helmholtz Zentrum München, München, Germany

    X
  • Maaike E. Ressing,

    Affiliation: Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands

    X
  • Emmanuel J. H. J. Wiertz,

    Affiliation: Department of Medical Microbiology, University Medical Centre Utrecht, Utrecht, The Netherlands

    X
  • Jaap M. Middeldorp,

    Affiliation: Department of Pathology, VU University Medical Centre, Amsterdam, The Netherlands

    X
  • Martin Rowe,

    Affiliation: School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom

    X
  • Alan B. Rickinson,

    Affiliation: School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom

    X
  • Andrew D. Hislop mail

    hislopad@adf.bham.ac.uk

    Affiliation: School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom

    X
  • Published: June 26, 2009
  • DOI: 10.1371/journal.ppat.1000490

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.